Security key
31189P102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 93,763,343
- Total 13F value
- $7,731,987,612
- Share change
- +6,756,194
- Put/Call ratio
- 121%
- SEC-reported price per share
- $82.45
- Number of holders
- 251
- Value change
- +$546,947,235
- Number of buys
- 133
- Number of sells
- 123
- Shares outstanding
- 115,488,632
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
251
Top holders
10
FATE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Ownership snapshot
Top reported holders of FATE - FATE THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $1,148,422,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC has the largest disclosed position value at $1.15B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Disclosed position value
Top 5
Redmile Group, LLC
$1.15B
FMR LLC
$691.51M
VANGUARD GROUP INC
$616.38M
BlackRock Finance, Inc.
$606.64M
PRICE T ROWE ASSOCIATES INC /MD/
$319.25M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
Company
|
—
denominator unverified
|
$1,148,422,000
12,629,737 shares
|
— | 31 Dec 2020 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$691,514,000
7,604,904 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$616,376,000
6,778,587 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$606,642,000
6,671,541 shares
|
— | 31 Dec 2020 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
denominator unverified
|
$319,253,000
3,510,970 shares
|
— | 31 Dec 2020 |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
Company
|
—
denominator unverified
|
$307,258,000
3,379,064 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
251
Shares
93,763,343
Rows available
251
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
251
Q1 2021 holders
251
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend